Previous 10 | Next 10 |
2024-06-12 17:45:04 ET Summary Kenvue (KVUE) was created as the result of a spinoff from Johnson & Johnson and encompasses the consumer side of the business. KVUE manages a wide array of products within each segment, but sales volume remains vulnerable to consumer spending. ...
2024-06-12 16:38:08 ET Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference Call June 12, 2024, 02:00 PM ET Company Participants Jennifer Taubert - Executive Vice President, Innovative Medicine John Reed - Executive Vice President, Innov...
2024-06-12 15:34:26 ET More on Johnson & Johnson Johnson & Johnson: Market Will Regret The Overreaction Johnson & Johnson (JNJ) Bernstein's 40th Annual Strategic Decisions Conference - (Transcript) Johnson & Johnson: Vital Signs Decent, A Compelling V...
2024-06-12 09:00:00 ET Summary Kenvue is a stock with a 4.4% yield and potential for long-term growth as a result of their strong brands like Tylenol, Neutrogena, and Listerine. The company reported solid earnings and organic growth in a challenging environment. Kenvue's segme...
2024-06-12 06:10:00 ET No investment in the equity markets (or anywhere else, for that matter) is entirely risk-free. However, some stocks look safe enough to allow investors to rest easy at night, knowing the shares are highly unlikely to experience significant losses. Though corporations ...
2024-06-11 18:22:39 ET Summary What is a Dividend King? A stock with 50 or more consecutive years of dividend increases.”—suredividend.com. The 53 Dividend Kings, screened as of June 7, represented 9 of 11 Morningstar Sectors. Broker-targeted top-ten net-gains ranged...
2024-06-11 14:04:25 ET More on Johnson & Johnson Johnson & Johnson: Market Will Regret The Overreaction Oregon jury awards talc plaintiff $260M in verdict against Johnson & Johnson Johnson & Johnson: Vital Signs Decent, A Compelling Value Case ...
2024-06-11 07:15:04 ET Bank of America Securities analyst issues NEUTRAL recommendation for JNJ on June 11, 2024 05:27AM ET. The previous analyst recommendation was Neutral. JNJ was trading at $147.13 at issue of the analyst recommendation. The overall analyst consensus ...
2024-06-10 09:00:00 ET Summary Invesco Dow Jones Industrial Average Dividend ETF holds the 28 stocks of the Dow Jones paying a dividend, weighted based on yields. DJD is better balanced across sectors than its parent index but is quite concentrated in its top holdings. DJD loo...
2024-06-09 16:23:25 ET Read the full article on Seeking Alpha For further details see: Stocks with the highest and lowest liquidity - Goldman Sachs
News, Short Squeeze, Breakout and More Instantly...
Health Canada Authorizes RYBREVANT® (amivantamab) in Combination with Carboplatin and Pemetrexed as the Only Targeted First-line Treatment Approved for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations Canada NewsWire Phase 3 PAPILLON study sh...
CARVYKTI® (ciltacabtagene autoleucel) achieved statistically significant and clinically meaningful improvement in overall survival in landmark CARTITUDE-4 study PR Newswire CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved by the U.S....
2024-07-01 06:50:00 ET Most retirees prefer low turnover in their investment portfolios. The less drama, the better. That way, they can focus on doing what they enjoy instead of worrying about their investments. Three Motley Fool contributors think they've found magnificent stocks retir...